Pay in 4 interest-free payments of $6.07 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Write your new syringe units on a note and attach it to the vial
However, retatrutide is still investigational and is not currently approved in the UK
To get started, complete your intake form and book your 1-on-1 assessment with one of our weight loss experts
These include: Nausea (affecting 20-40% of patients, though often transient) Vomiting and diarrhoea Constipation Abdominal pain and bloating Reduced appetite (which, whilst therapeutically desired, can occasionally be excessive) These effects typically diminish over several weeks as the body adjusts to the medication
CLA (Konjugierte Linolsuren) Kann das Fettgewebe reduzieren, aber nur minimal
Protocol 4: Post-menopausal metabolic restoration Goal: Address menopausal weight gain and metabolic changes Stack: Tirzepatide: Standard protocol (addresses insulin resistance) Tesamorelin: 1-2mg daily (visceral fat) CJC-1295/Ipamorelin: 200mcg each before bed (body composition, bone density) Resistance training: 3-4x per week Adequate protein and calcium Duration: 12+ months, potentially ongoing Expected results: 25-45 pounds weight loss Reduced visceral fat Improved insulin sensitivity Better body composition Maintained bone density Why this works: Addresses multiple menopausal factors - insulin resistance, visceral fat, muscle loss, bone density
US$ 25.10
US$ 24.12
US$ 21.25
US$ 28.90
